Generalized bullous fixed drug eruption mimicking Stevens-Johnson syndrome: a case report
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20262758Keywords:
Bullous fixed drug eruption, Adverse drug reaction, Levofloxacin, Ornidazole, SJS-TEN mimicAbstract
Bullous fixed drug eruption (BFDE) is a rare but severe cutaneous adverse drug reaction that may mimic Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). A 58-year-old male with diabetes, hypertension, and coronary artery disease developed multiple erythematous and bullous lesions within 24 hours of initiating levofloxacin and ornidazole for a nail bed infection. He had a prior history of similar reaction. Clinical diagnosis of generalized BFDE was made based on history and presentation. Naranjo score indicated a possible adverse drug reaction. The suspected drugs were discontinued. The patient was managed conservatively with topical steroids, antihistamines, and supportive care. The patient improved with residual hyperpigmentation. Early recognition and differentiation from SJS/TEN are crucial to avoid unnecessary aggressive treatment and prevent recurrence.
References
Loo LY, Ngiam NHW, Sultana R, Lee HY. Generalized Bullous Fixed Drug Eruption: A Systematic Review. The journal of allergy and clinical immunology In practice. 2026;14(3):668–75.
Mathur M, Paudel S, Bhattarai N, Karki S, Regmi S. Generalized Bullous Fixed Drug Eruption Secondary to Levocetirizine: A Lesson Learned! Clinical Case Reports. 2025;13(11):26-9.
Jhaj R, Chaudhary D, Asati D, Sadasivam B. Fixed-drug Eruptions: What can we Learn from a Case Series? Indian Journal of Dermatology. 2018;63(4):332–7.
Nagakeerthana S, Rangaraj M, Karthikeyan K. One Drug-Two Similar Reactions. Report of cases of Ciprofloxacin induced Stevens-Johnson Syndrome and Bullous fixed drug eruption. Journal of Young Pharmacists. 2016;8(2):161–3.
Patell RD, Dosi RV, Shah PC, Joshi HS. Widespread bullous fixed drug eruption. Case Reports. 2014;2014(2):bcr2013200584–4.
Ben Fadhel N, Chaabane A, Ammar H, Ben Romdhane H, Soua Y, Chadli Z, et al. Clinical features, culprit drugs, and allergology workup in 41 cases of fixed drug eruption. Contact Dermatitis. 2019;81(5):336–40.
Anderson HJ, Lee JB. A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption. Medicina. 2021;57(9):925.
Singh R, Sudhanshu VK, Shafiq M, Sharma M. Generalized bullous fixed drug eruption induced by chlordiazepoxide: a case report of a potentially lethal adverse effect. Consortium PSYCHIATRICUM. 2025;6(1):30–6.
Paulmann M, Reinkemeier F, Lehnhardt M, Mockenhaupt M. Case report: Generalized bullous fixed drug eruption mimicking epidermal necrolysis. Frontiers in Medicine. 2023;10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC10461315/#:~:text=Generalized%20bullous%20fixed%20drug%20eruption%20is%20a%20rare%20and%20severe. Accessed 28 April 2026.
Wang Y, Xue H, Dai H, Yang L. Cross-Reactivity: a Case of Paracetamol-Induced Generalized Bullous Fixed Drug Eruption Followed by Dipyrone-Induced Fixed Drug Eruption. Clinical Cosmetic and Investigational Dermatology. 2025;18:785–9.
Choi S, Kim SH, Hwang JH, Jang HW, Oh SH, Kim DY, et al. Rapidly progressing generalized bullous fixed drug eruption after the first dose of COVID-19 messenger RNA vaccination. The Journal of dermatology. 2023;50(9):1190–3.
Downloads
Published
How to Cite
Issue
Section
